Be part of the knowledge.™

Neurology and Neurosurgery

66

LikeLikedUnlike

31-45 of 91

Minimal By Design: Define MSE Endpoints
MinuteCE®
Minimal By Design: Define MSE Endpoints
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credits
The IgG Clock: Redose Using IgG Kinetics
MinuteCE®
The IgG Clock: Redose Using IgG Kinetics
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 program credits
MinuteCE®
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
- Christyn Edmundson, MD
- Gil I. Wolfe MD, FAAN
1.00 credits 10 episodes
Early Clues, Lasting Impact: Detecting and Treating Alzheimer’s Disease in Its Earliest Stages
CME/CE
Early Clues, Lasting Impact: Detecting and Treating Alzheimer’s Disease in Its Earliest Stages
- Anton P. Porsteinsson, MD
- Vijay K. Ramanan, MD, PhD
1.00 credits
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
CME/CE
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
- Emily D. Clark, DO
- Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA
- Susan Scanland, MSN, CRNP, GNP-BC, CDP
- Anthony J. Viera, MD, MPH
1.00 credits
New Pathways in the Treatment of DMD
CME/CE
New Pathways in the Treatment of DMD
- Erika Finanger, MD, MS
- Aravindhan Veerapandiyan, MD
1.00 credits
advertisement
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
CME/CE
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
- Stephen Chrzanowski, MD, PhD
- Aravindhan Veerapandiyan, MD
1.00 credits
From Pain to Possibilities: Safe Opioid Use and Treatment of Patients with Pain
CME/CE
From Pain to Possibilities: Safe Opioid Use and Treatment of Patients with Pain
- Lisa Phipps, PharmD, PhD
- Michael Sprintz, DO, DFASAM
- Amanda Zimmerman, PA-C
2.00 credits
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
CME/CE
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
- Christoph U. Correll, MD
- Jonathan M. Meyer
0.25 credits
Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology
CME/CE
Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology
- Neelam Goyal, MD
- Christyn Edmundson, MD
0.50 credits
Not Just a Headache: Migraine Across Women’s Lifespan
CME/CE Broadcast Replay
Not Just a Headache: Migraine Across Women’s Lifespan
- Jelena Pavlović, MD, PhD
- Amaal J. Starling, MD, FAHS, FAAN
1.00 credits
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
CME/CE
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
- Marwan Sabbagh, MD, FAAN
- Alireza Atri, MD, PhD
- Christoph U. Correll, MD
1.00 credits
advertisement
Treatment of a Broader Population of Patients With DMD
CME/CE
Treatment of a Broader Population of Patients With DMD
- Crystal Proud, MD
- Erika Finanger, MD, MS
1.00 credits
Recognizing Early Signs of LGMD2I/R9 
MinuteCE®
Recognizing Early Signs of LGMD2I/R9 
- John Vissing, MD, DMSci
1.00 program credits
MinuteCE®
Establishing Our Foundation of LGMD2I/R9
- John Vissing, MD, DMSci
- Conrad Weihl, MD, PhD
1.00 credits 8 episodes

Program Chapters

Segment Chapters

Playlist:

Recommended